Medicared For All Logo

Kenneth Sabatino MD in Clearwater, Florida

Home Florida Clearwater

Kenneth Sabatino MD has Cardiovascular Disease (cardiology) as his primary medical specialty. Their primary office is: 300 Pinellas St in Clearwater, Florida. There is an additional office location, for a total of two, for Kenneth Sabatino MD that can be viewed further down.

They're a part of the: Pinellas Ekg Interpreters Inc medical group which has around 51 members. You can call their office at 727-462-7000 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Temple University School Of Medicine and graduated in 1991 (around 33 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.


Kenneth C Sabatino MD Office Phone and Directions

Kenneth Sabatino MD
Pinellas Ekg Interpreters Inc
300 Pinellas St
Clearwater, Florida 33756
727-462-7000


Patient Ratings
Please rate your experience with Kenneth Sabatino MD below to help others make a more informed decision. Thanks!
Current Rating: Loading...

Phone: 727-462-7000


Enter a starting address:


Healthcare Info for Kenneth Sabatino MD

Medical School: Temple University School Of Medicine
Graduation Year: 1991
The Primary Medical Specialty for Kenneth Sabatino MD is listed as: Cardiovascular Disease (cardiology)
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 33
PAC (PECOS ID)#: 0446215917
NPI #: 1003805664
NPI Created On: 10/17/2005
NPI Last Updated Listed as: 11/15/2018
Primary Taxonomy Code: 207RC0000X
License Number:
ME83659
Listed Gender: Male

Insurance, Services, Charges


Forms of insurance accepted by include, but are not limited to:

  • Humana
  • Blue Cross Blue Shield
  • Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English, Spanish.


Services and Procedures include:

  1. External ekg recording for more than 48 hours up to 21 days
  2. Review and interpretation of external ekg recording for more than 48 hours up to 21 days
  3. Nuclear medicine study of vessels of heart using drugs or exercise multiple studies
  4. Blood test, clotting time
  5. External shock to heart to regulate heart beat
  6. Routine ekg using at least 12 leads including interpretation and report
  7. Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report
  8. Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician supervision, interpretation, and report
  9. Heart rhythm tracing, analysis, and interpretation of 48-hour ekg
  10. Heart rhythm tracing, computer analysis, and interpretation of patient-triggered events greater than 24-hour ekg up to 30 days
  11. Evaluation, testing, and programming adjustment of permanent dual lead pacemaker system with physician analysis, review, and report
  12. Remote evaluations of single, dual, or multiple lead pacemaker system or implantable defibrillator system with technician review, support and distribution of results, up to 90 days
  13. Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function
  14. Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function
  15. Insertion of probe in esophagus for heart ultrasound examination including interpretation and report
  16. Doppler ultrasound study of heart blood flow, valves, and chambers
  17. Doppler ultrasound study of heart blood flow, valves, and chambers
  18. Doppler ultrasound study of color-directed heart blood flow, rate, and valve function
  19. Doppler ultrasound study of color-directed heart blood flow, rate, and valve function
  20. Ultrasound examination and continuous monitoring of the heart performed during rest, exercise, and/or drug-induced stress with interpretation and report

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.


Payments Total: $13

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783509093

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular

Name of Drug #1: ELIQUIS

Open Associated Drug #1: 0003-0894-31


Payments Total: $15

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783509253

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular

Name of Drug #1: ELIQUIS

Open Associated Drug #1: 0003-0894-31


Payments Total: $19

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 768789542

Being Disputed:: No

Product Related: Yes

Drug or Biological: Device

Product Category #1: Electromedical and Electrotherapeutic Apparatus

Name of Drug #1: LifeVest


Payments Total: $11

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 768815260

Being Disputed:: No

Product Related: Yes

Drug or Biological: Device

Product Category #1: Electromedical and Electrotherapeutic Apparatus

Name of Drug #1: LifeVest


Payments Total: $5

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Context of payment:: Informational Meal

Record ID:: 829722203

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular and Metabolism

Name of Drug #1: FARXIGA

Open Associated Drug #1: 0310-6205-30


Payments Total: $125

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Context of payment:: Educational Program

Record ID:: 829838041

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular and Metabolism

Name of Drug #1: FARXIGA

Open Associated Drug #1: 0310-6205-30


Additional Office Locations

1. Clearwater Cardiovascular And Interventional Consultants Md Pa
1840 Mease Dr
Safety Harbor, FL 34695
Suite 202
Group Members: 22

Phone: 727-462-7000

Enter a starting address:


Cardiovascular Disease (cardiology) Professionals in Clearwater

455 Pinellas St
Clearwater, FL
Morton Plant Mease Diagnostic Cardiology Llc

323 Jeffords St
Clearwater, FL
Pinellas Ekg Interpreters Inc

2461 Enterprise Rd
Clearwater, FL
Baycare Medical Group, Inc.

455 Pinellas St
Clearwater, FL
Baycare Medical Group, Inc.

2461 Enterprise Rd
Clearwater, FL
Baycare Medical Group, Inc.

3231 N Mcmullen Booth Rd
Clearwater, FL

Providers in Pinellas Ekg Interpreters Inc

1.Michael Barry

300 Pinellas St
Clearwater Fl 33756-3804
Pinellas Ekg Interpreters Inc
Cardiovascular Disease (cardiology)

2.Carlos Bayron Md

3231 Mcmullen Booth Rd
Safety Harbor Fl 34695-6607
Pinellas Ekg Interpreters Inc
Cardiovascular Disease (cardiology)

3.Carlos Bayron Md

601 Main St
Dunedin Fl 34698-5848
Pinellas Ekg Interpreters Inc
Cardiovascular Disease (cardiology)

4.Vikas Bhatia

1200 7th Ave N
St Petersburg Fl 33705-1300
Pinellas Ekg Interpreters Inc
Cardiovascular Disease (cardiology)

5.Vikas Bhatia

601 Main St
Dunedin Fl 34698-5848
Pinellas Ekg Interpreters Inc
Cardiovascular Disease (cardiology)

6.Robert Black Md

3231 Mcmullen Booth Rd
Safety Harbor Fl 34695-6607
Pinellas Ekg Interpreters Inc
Cardiovascular Disease (cardiology)

View all 51 members of Pinellas Ekg Interpreters Inc medical group